Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nurix Therapeutics (NRIX) Return on Assets (2020 - 2026)

Nurix Therapeutics (NRIX) has disclosed Return on Assets for 7 consecutive years, with 0.45% as the latest value for Q1 2026.

  • Quarterly Return on Assets fell 12.0% to 0.45% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.45% through Feb 2026, down 12.0% year-over-year, with the annual reading at 0.39% for FY2025, 1.0% down from the prior year.
  • Return on Assets for Q1 2026 was 0.45% at Nurix Therapeutics, down from 0.44% in the prior quarter.
  • The five-year high for Return on Assets was 0.3% in Q1 2022, with the low at 0.45% in Q1 2023.
  • Average Return on Assets over 5 years is 0.4%, with a median of 0.41% recorded in 2022.
  • The sharpest move saw Return on Assets fell -17bps in 2022, then rose 11bps in 2024.
  • Over 5 years, Return on Assets stood at 0.41% in 2022, then dropped by -5bps to 0.43% in 2023, then grew by 25bps to 0.33% in 2024, then plummeted by -33bps to 0.44% in 2025, then dropped by -2bps to 0.45% in 2026.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.45%, 0.44%, and 0.44% for Q1 2026, Q4 2025, and Q3 2025 respectively.